ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CLIN Clinigen Group Plc

925.00
0.00 (0.00%)
16 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Clinigen Group Plc LSE:CLIN London Ordinary Share GB00B89J2419 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 925.00 924.50 925.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

BARCLAYS PLC: Form 8.5 (EPT/NON-RI) - CLINIGEN GROUP PLC - Amendment

14/01/2022 1:40pm

UK Regulatory


Clinigen (LSE:CLIN)
Historical Stock Chart


From Jul 2021 to Jul 2024

Click Here for more Clinigen Charts.
TIDMCLIN TIDMBARC 
 
 

FORM 8.5 (EPT/NON-RI) Amendment to 2(b)Rights to subscribe for new securities previously disclosured

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

 

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

 

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 
(a) Name of exempt principal trader:    BARCLAYS CAPITAL SECURITIES LTD 
(b) Name of offeror/offeree in          CLINIGEN GROUP PLC 
relation to whose relevant securities 
this form relates: Use a separate form 
for each offeror/offeree 
(c) Name of the party to the offer      Triley Bidco Limited (a newly-formed 
with which exempt principal trader is   company indirectly owned by Triton 
connected:                              Funds) 
(d) Date position held/dealing          13 January 2022 
undertaken: For an opening position 
disclosure, state the latest 
practicable date prior to the 
disclosure 
(e) In addition to the company in 1(b)  NO 
above, is the exempt principal trader 
making disclosures in respect of any 
other party to the offer? If it is a 
cash offer or possible cash offer, 
state "N/A" 
 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 
Class of relevant security:                0.1p ordinary 
                                           Interests         Short Positions 
                                           Number     (%)    Number      (%) 
(1)        Relevant securities owned 
           and/or controlled:              1,895,939  1.42%  449,856     0.34% 
 
(2)        Cash-settled derivatives: 
                                           412,040    0.31%  1,618,465   1.21% 
 
           Stock-settled derivatives 
(3)        (including options) 
           and agreements to 
           purchase/sell:                  0          0.00%  0           0.00% 
 
(4) 
           TOTAL:                          2,307,979  1.73%  2,068,321   1.55% 
 
 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 
Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 
 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 
Class of        Purchase/sale    Total number     Highest price  Lowest price 
relevant                         of               per unit       per unit 
security                         securities       paid/received  paid/received 
0.1p ordinary   Purchase         115,990          9.1095 GBP     9.0745 GBP 
0.1p ordinary   Sale             21,961           9.1095 GBP     9.0813 GBP 
 

(b) Cash-settled derivative transactions

 
Class of         Product        Nature of dealing    Number of   Price per 
relevant         description                         reference   unit 
security                                             securities 
0.1p ordinary    SWAP           Decreasing Long      250         9.1000 GBP 
0.1p ordinary    SWAP           Decreasing Long      737         9.0823 GBP 
0.1p ordinary    SWAP           Increasing Long      275         9.0900 GBP 
0.1p ordinary    SWAP           Increasing Long      505         9.0719 GBP 
0.1p ordinary    SWAP           Increasing Long      1,209       9.0818 GBP 
0.1p ordinary    SWAP           Increasing Long      1,364       9.0923 GBP 
0.1p ordinary    SWAP           Increasing Long      1,696       9.0865 GBP 
0.1p ordinary    CFD            Increasing Long      4,633       9.0787 GBP 
0.1p ordinary    SWAP           Increasing Short     89,309      9.0745 GBP 
 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 
Class of  Product      Writing,     Number of   Exercise  Type e.g.  Expiry  Option 
relevant  description  purchasing,  securities  price     American,  date    money 
security  e.g. call    selling,     to which    per       European           paid/ 
          option       varying      option      unit      etc.               received 
                       etc.         relates                                  per 
                                                                             unit 
 
 

(ii) Exercise

 
Class of        Product         Exercising/     Number of       Exercise price 
relevant        description     exercised       securities      per unit 
security        e.g. call       against 
                option 
 
 

(d) Other dealings (including subscribing for new securities)

 
Class of relevant       Nature of dealing      Details  Price per unit (if 
security                e.g. subscription,              applicable) 
                        conversion 
 
 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 
Details of any indemnity or option arrangement, or any agreement or 
understanding, formal or informal, relating to relevant securities which may 
be an inducement to deal or refrain from dealing entered into by the exempt 
principal trader making the disclosure and any party to the offer or any 
person acting in concert with a party to the offer: Irrevocable commitments 
and letters of intent should not be included. If there are no such agreements, 
arrangements or understandings, state "none" 
 
 None 
 

(b) Agreements, arrangements or understandings relating to options or derivatives

 
Details of any agreement, arrangement or understanding, formal or informal, 
between the exempt principal trader making the disclosure and any other person 
relating to: (i) the voting rights of any relevant securities under any 
option; or (ii) the voting rights or future acquisition or disposal of any 
relevant securities to which any derivative is referenced: If there are no 
such agreements, arrangements or understandings, state "none" 
 
 None 
 

(c) Attachments

 
Is a Supplemental Form 8 (Open Positions) attached?  NO 
 
 
Date of disclosure:   14 Jan 2022 
Contact name:         Large Holdings Regulatory Operations 
Telephone number:     020 3134 7213 
 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20220114005248/en/

 
    CONTACT: 

BARCLAYS PLC

 
    SOURCE: BARCLAYS PLC 
Copyright Business Wire 2022 
 

(END) Dow Jones Newswires

January 14, 2022 08:40 ET (13:40 GMT)

1 Year Clinigen Chart

1 Year Clinigen Chart

1 Month Clinigen Chart

1 Month Clinigen Chart

Your Recent History

Delayed Upgrade Clock